Abnormal bone turnover in monoclonal gammopathy of undetermined significance: analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens-Reference-Cited by-同舟云学术

Abnormal bone turnover in monoclonal gammopathy of undetermined significance: analyses of type I collagen telopeptide, osteocalcin, bone-specific alkaline phosphatase and propeptides of type I and type III procollagens

Published:2009-04-24 Issue:2 Volume:58 Page:104-108
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Vejlgaard T.,Abildgaard N.,Jans H.,Nielsen J. Lanng,Heickendorff L.

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.1997.tb00932.x/fullpdf

Reference20 articles.

1. Monoclonal gammopathies of undetermined significance;Kyle;Semin Hematol,1989

2. Benign” Monoclonal Gammopathy - after 20 to 35 years of follow-up;Kyle;Mayo Clin Proc,1993

3. Serum markers of type I collagen formation and degradation in metabolic bone disease. Correlation to bone histomorphometry;Eriksen;J Bone Min Res,1993

4. Connective tissue components in serum in multiple myeloma: analysis of propeptides of Type I and Type III procollagens, Type I collagen telopeptide, and hyaluronan;Abildgaard;Am J Haematol,1994

5. Serum bone gla-protein in multiple myeloma;Bataille;Cancer,1987

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term Evolution of Hypophosphatemia and Osteomalacia in a Patient With Multiple Myeloma;JCEM Case Reports;2024-06-27

2. Treatment of an Impending Pathologic Sacral Fracture with a Novel Iliosacral Fusion Construct;JBJS Case Connector;2023-01

3. Bone Disease in Multiple Myeloma: Biologic and Clinical Implications;Cells;2022-07-27

4. What is the significance of monoclonal gammopathy of undetermined significance?;Clinical Medicine;2018-10

5. Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study;Blood Advances;2017-12-21